🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Nebulized dornase alfa inhalation solution may decrease the thic...
Status
Unknown
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2008-02
Trial ID
NCT00536952
Treatments Being Tested
Patients presenting to the emergency department with acute ischemic stroke,...
Status
Completed
Location
Princess Alexandra Hospital
Start Date
2022-02-18
Trial ID
NCT05203224
Treatments Being Tested
The purpose of this study is to evaluate whether a therapy that uses a mach...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT02168387
Treatments Being Tested
The hypothesis is that the intranasal use of Pulmozyme will decrease the se...
Status
Withdrawn
Location
Penn State Unicersity
Start Date
2013-07
Trial ID
NCT01155752
Treatments Being Tested
The purpose of this study is to determine whether Inhalation of Recombinant...
Status
Unknown
Location
University Hospital, Anaesthesiology
Start Date
2003-08
Trial ID
NCT00204685
Treatments Being Tested
This qualitative longitudinal study is designed to elicit and thematically ...
Status
Completed
Location
Johns Hopkins University
Start Date
2020-12-23
Trial ID
NCT04320381
Treatments Being Tested
Patients with Sjogren's disease have destruction of the mucus secreting cel...
Status
Withdrawn
Location
University of CT Health Center
Start Date
2011-05
Trial ID
NCT01357447
Treatments Being Tested
In patients with COVID-19, severe hypoxemic respiratory failure (SRF) leadi...
Status
Unknown
Location
University Hospital of Alexandroupolis
Start Date
2020-10-25
Trial ID
NCT05279391
This study evaluates the Safety,Tolerability, Pharmacokinetics and Explorat...
Status
Unknown
Location
Carmel MC
Start Date
2016-05
Trial ID
NCT02722122
Treatments Being Tested
This is a double-blind, randomised, 2 single-doses and then repeated-dose (...
Status
Completed
Location
JHL Biotech Investigational Site
Start Date
2018-01-26
Trial ID
NCT03586076
Treatments Being Tested